- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/18 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 307/18
Total number of patents in this class: 54
10-year publication summary
5
|
3
|
2
|
3
|
3
|
4
|
5
|
1
|
4
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
7 |
The University of Queensland | 663 |
7 |
Eastman Chemical Company | 2212 |
3 |
Taisho Pharmaceutical Co., Ltd. | 866 |
3 |
Toyama Chemical Co., Ltd. | 101 |
3 |
3m Innovative Properties Company | 17795 |
2 |
Syngenta Participations AG | 1847 |
2 |
Allergan, Inc. | 2337 |
2 |
Glaxosmithkline Intellectual Property Development Limited | 764 |
2 |
Modernatx, Inc. | 1284 |
2 |
Sichuan University | 572 |
2 |
Psyched Wellness Ltd. | 21 |
2 |
Bayer Schering Pharma AG | 381 |
1 |
Archer Daniels Midland Company | 1134 |
1 |
Grünenthal GmbH | 565 |
1 |
Hans R. Pfaendler | 1 |
1 |
Lakewood-amedex, Inc. | 31 |
1 |
Nanyang Technological University | 2035 |
1 |
National Institute of Biological Sciences, Beijing | 100 |
1 |
Novira Therapeutics, Inc. | 32 |
1 |
Other owners | 9 |